STAT3 and head and neck squamous cell carcinoma: Given the promise of the STAT3 decoy oligonucleotide as a therapeutic approach in HNSCC, we aimed to fully understand the mechanisms by which the STAT3 decoy oligonucleotide exerts its antitumor effects.